XML 51 R35.htm IDEA: XBRL DOCUMENT v3.25.3
Segment Reporting (Details)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
USD ($)
Jun. 30, 2025
USD ($)
Mar. 31, 2025
USD ($)
Sep. 30, 2024
USD ($)
Jun. 30, 2024
USD ($)
Mar. 31, 2024
USD ($)
Sep. 30, 2025
USD ($)
segment
Sep. 30, 2024
USD ($)
Segment Reporting Information [Line Items]                
Number of reportable segments | segment             1  
License revenue $ 0     $ 1,000     $ 0 $ 1,000
Operating expenses                
Total operating expenses 48,023     35,438     146,099 97,541
Operating loss (48,023)     (34,438)     (146,099) (96,541)
Other income, net 371     2,087     2,237 6,545
Net loss (47,652) $ (49,191) $ (47,019) (32,351) $ (30,498) $ (27,147) (143,862) (89,996)
Reportable Segment                
Segment Reporting Information [Line Items]                
License revenue 0     1,000     0 1,000
Operating expenses                
Compensation and benefits 15,801     13,081     48,139 41,010
Clinical trial and manufacturing 21,559     6,334     51,239 14,172
Facilities and IT 3,481     9,563     21,274 26,125
Other research and development 2,125     1,572     7,083 3,298
Other segment 5,057     4,888     18,364 12,936
Total operating expenses 48,023     35,438     146,099 97,541
Operating loss (48,023)     (34,438)     (146,099) (96,541)
Other income, net 371     2,087     2,237 6,545
Net loss $ (47,652)     $ (32,351)     $ (143,862) $ (89,996)